|Market Size in 2022||Market Forecast in 2030||CAGR (in %)||Base Year|
|USD 5.3 Billion||USD 8.7 Billion||6.5%||2022|
Effervescent Tablet Market
The global effervescent tablet market size was worth around USD 5.3 billion in 2022 and is predicted to grow to around USD 8.7 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.5% between 2023 and 2030.
The report analyzes the global effervescent tablet market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the effervescent tablet industry.
An effervescent tablet is a pharmaceutical dosage form that is designed to dissolve quickly in water, releasing carbon dioxide gas and creating a pleasant fizzy, or effervescent reaction. These tablets are commonly used to deliver medications, vitamins, minerals, or other active ingredients in a convenient and easy-to-use format. The tablets typically consist of a mixture of active ingredients, such as drugs or nutrients, along with various excipients and a source of carbon dioxide. The tablet is usually compressed using a combination of citric acid and sodium bicarbonate, which react when dissolved in water to produce carbon dioxide bubbles. This effervescence helps to disperse the tablet's contents throughout the water, aiding in their absorption and making it easier to consume. One of the advantages of effervescent tablets is that they can provide a more rapid onset of action compared to traditional tablets or capsules. The effervescence increases the surface area and promotes the dissolution of the tablet, allowing the active ingredients to be absorbed more quickly by the body.
Additionally, the fizzy nature of effervescent tablets can make them more palatable for those who have difficulty swallowing traditional tablets. Effervescent tablets are commonly used for the administration of various medications, including pain relievers, antacids, cold and flu remedies, and nutritional supplements. They are also popular for dietary supplements, such as vitamin C or multivitamins, as they can enhance absorption and improve compliance due to their pleasant taste and ease of use. The global effervescent tablet market is driven by various factors including the growing geriatric population, increasing demand for dietary supplements, increasing innovation and product development, and increasing prevalence of the respiratory disease.
The growing incidence of chronic disease drives the market growth
The market for effervescent tablets is anticipated to expand in the future due to the rising incidence rate of chronic disorders. Chronic conditions frequently persist for three months or more and might get worse over time. Cancer, heart disease, stroke, diabetes, and rheumatoid arthritis are the most common chronic diseases. As an effective antioxidant that raises blood antioxidant levels and lowers the risk of chronic diseases, effervescent pills are used in the treatment of chronic conditions including diabetes, cancer, and heart disease. For instance, according to the World Health Organization, cardiovascular diseases will be the top cause of death globally in 2021, taking an estimated 17.9 million lives annually. Furthermore, the public research institution Imperial College London in the UK estimates that by September 2020, chronic diseases—which account for about 41 million deaths annually—will be the primary cause of seven out of ten fatalities globally. Therefore, the market for effervescent tablets is expanding due to the increased incidence rate of chronic disorders.
Stability and shelf life impede the market growth
Effervescent tablets are sensitive to moisture and air, which can affect their stability and shelf life. The effervescent reaction, which involves the release of carbon dioxide gas upon dissolution, can lead to the degradation of the active ingredients over time. Maintaining the integrity and potency of the tablets throughout their shelf life requires careful packaging and storage conditions. Ensuring stability can be a challenge for manufacturers and may require additional investments in packaging materials and quality control processes. Thus, the stability and shelf life concerns among the manufacturers are expected to hamper the effervescent tablet market growth over the analysis period.
Technological advancement offers a significant opportunity
A crucial trend that is becoming increasingly popular in the effervescent tablet industry is technological improvement. To maintain their position in the market, major manufacturers are focusing on developing cutting-edge production methods. For instance, Health Innovations Ltd., a UK-based manufacturer of healthcare supplements, introduced EfferShield technology in April 2022. For effervescent tablets and powders, there is a patent-matched technology called EfferShield. Customers have more flexible and easy packaging alternatives with the possibility of recycling and at-home composting due to the product's availability in single-use pouch and stick-pack packaging. Thus, technological advancements are expected to offer a lucrative opportunity for market growth during the projected period.
Lack of awareness poses a major challenge
While the popularity of effervescent tablets is growing, there may still be a lack of awareness and understanding among consumers about their benefits and availability. Many individuals may be accustomed to traditional tablet or capsule forms and may not be aware of the convenience and advantages offered by effervescent tablets. Educating consumers and healthcare professionals about the efficacy and appropriate use of effervescent tablets is crucial for the effervescent tablet market expansion. Thereby, a lack of awareness among consumer poses a major challenge for market expansion.
The global effervescent tablet industry is segmented based on product, methods, indication, application, end user, and region.
Based on the product, the global market is bifurcated into medication and supplements. The supplements segment is expected to grow at the fastest rate during the forecast period. Effervescent tablets are designed to dissolve quickly and completely in water. This enhanced solubility leads to better bioavailability of active ingredients compared to traditional tablets or capsules. The effervescence helps disperse the supplement throughout the liquid, ensuring even distribution and improved absorption in the body. Moreover, effervescent tablets offer a convenient and user-friendly way to take supplements. They can be easily dissolved in a glass of water, creating a fizzy and flavored drink that is easy to consume. This format is especially advantageous for those who have difficulty swallowing pills or prefer a more enjoyable method of taking supplements. Thereby, driving the segment growth.
Based on the methods, the global effervescent tablet industry is divided into dry methods and wet granulation.
Based on the indication, the global effervescent tablet industry is bifurcated into pain management, diuretics, gastric disorders, respiratory diseases, and others. The pain management segment is expected to capture the largest market share over the forecast period. This tablet can be formulated to contain analgesic medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen (paracetamol). These medications are commonly used to alleviate various types of pain, including headaches, muscle aches, joint pain, and minor injuries. Thus, this is expected to fuel the growth of the market during the forecast period.
Based on the application, the market is segmented into dental products, dietary supplements, pharmaceuticals, and others.
Based on the end user, the market is segmented into hospitals, specialty clinics, homecare, and others.
|Report Attributes||Report Details|
|Report Name||Effervescent Tablet Market Research Report|
|Market Size in 2022||USD 5.3 Billion|
|Market Forecast in 2030||USD 8.7 Billion|
|Growth Rate||CAGR of 6.5%|
|Number of Pages||227|
|Key Companies Covered||Bayer AG, Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Perrigo Company plc, Reckitt Benckiser Group PLC, GSK plc, CHIESI SAS, Hermes Pharma, S. G. Biopharm Pvt. Ltd, Bliss GVS Pharma Limited, Alpex, SCITECH, Vovantis Laboratories, Swisse Wellness PTY LTD, Herbalife International of America Inc., Nuun, Natur Produkt Zdrovit Sp Z O O, Vitabiotics Ltd, Amerilab Technologies Inc. and HERMES ARZNEIMITTEL among others.|
|Segments Covered||By Product, By Methods, By Indication, By Application, By End User, and By Region|
|Regions Covered||North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)|
|Historical Year||2017 to 2021|
|Forecast Year||2023 - 2030|
|Customization Scope||Avail customized purchase options to meet your exact research needs. Request For Customization|
North America is expected to dominate the market during the forecast period
North America is expected to dominate the effervescent tablet market during the forecast period. The regional growth is ascribed to various factors such as the growing prevalence of chronic disorders and the presence of major market players. For instance, as per CDC data, in the United States, 1,603,844 new instances of cancer were reported in 2020, and 602,347 cancer-related deaths were recorded. 403 new instances of cancer and 144 cancer-related deaths were recorded for every 100,000 persons. Furthermore, the increasing geriatric population and the growing innovative product launches in the region propel the market revenue.
The Asia Pacific is expected to grow at the highest CAGR over the forecast period owing to the growing health consciousness among the population. The region has seen a rise in health consciousness and awareness among the population. Consumers are becoming more proactive in managing their health and seeking preventive healthcare solutions, including dietary supplements. Effervescent tablets offer a convenient and enjoyable way to consume supplements, aligning with the growing demand for health and wellness products.
The global effervescent tablet market is dominated by players like:
By End User
An effervescent tablet is a pharmaceutical dosage form that is designed to dissolve quickly in water, releasing carbon dioxide gas and creating a pleasant fizzy, or effervescent reaction. These tablets are commonly used to deliver medications, vitamins, minerals, or other active ingredients in a convenient and easy-to-use format.
The convenience of use offered by these tablets—they dissolve quickly in water—is the primary driver behind the expansion of the worldwide market for effervescent tablets. One of the main factors fueling the demand for the global effervescent tablet market is the increasing awareness of physical care among consumers. These tablets include pre-biotics, pre-workout, dietary supplements, glucose tabs, and others that can help a person in leading a healthier lifestyle.
According to the report, the global market size was worth around USD 5.3 billion in 2022 and is predicted to grow to around USD 8.7 billion by 2030.
The global effervescent tablet market is expected to grow at a CAGR of 6.5% during the forecast period.
The global effervescent tablet market growth is expected to be driven by North America. It is currently the world’s highest revenue-generating market owing to the well-developed healthcare infrastructure and the presence of major market players.
The global effervescent tablet market is dominated by players like Bayer AG, Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Perrigo Company plc, Reckitt Benckiser Group PLC, GSK plc, CHIESI SAS, Hermes Pharma, S. G. Biopharm Pvt. Ltd, Bliss GVS Pharma Limited, Alpex, SCITECH, Vovantis Laboratories, Swisse Wellness PTY LTD, Herbalife International of America, Inc., Nuun, Natur Produkt Zdrovit Sp Z O O, Vitabiotics Ltd, Amerilab Technologies Inc. and HERMES ARZNEIMITTEL among others.